Marine Drugs · 2015 · 32 citations · 10 references
PharmacyMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoveryStructure-activity RelationshipsEnzyme InhibitionMarine Bioactive CompoundsMarine Drug DiscoveryMarine Natural ProductsNatural Product Drug DiscoveryStructure-activity Relationship AnalysisAnticancer Marine CompoundsBioactive Compounds From Marine SpongesBioactive Marine MetabolitesEnzyme Inhibitors From Marine SourcesMarine Sponge MetabolitesMarine-derived Anticancer CompoundsMarine-derived Enzyme InhibitorsSponges As Drug Sources
Seven new adociaquinone derivatives, xestoadociaquinones A (1a), B (1b), 14-carboxy-xestoquinol sulfate (2) and xestoadociaminals A-D (3a, 3c, 4a, 4c), together with seven known compounds (5-11) were isolated from an Indonesian marine sponge Xestospongia sp. Their structures were elucidated by extensive 1D and 2D NMR and mass spectrometric data. All the compounds were evaluated for their potential inhibitory activity against eight different protein kinases involved in cell proliferation, cancer, diabetes and neurodegenerative disorders as well as for their antioxidant and antibacterial activities.
10
Tania Tahtouh, Jonathan M. Elkins, P. Filippakopoulos et al. · Journal of Medicinal Chemistry · 2012 · 188 citations · Full text